NO961808L - Konstruksjon og produksjon av vaksine - Google Patents
Konstruksjon og produksjon av vaksineInfo
- Publication number
- NO961808L NO961808L NO961808A NO961808A NO961808L NO 961808 L NO961808 L NO 961808L NO 961808 A NO961808 A NO 961808A NO 961808 A NO961808 A NO 961808A NO 961808 L NO961808 L NO 961808L
- Authority
- NO
- Norway
- Prior art keywords
- val
- ile
- leu
- gly
- ala
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010006262 Breast inflammation Diseases 0.000 abstract 1
- KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 210000000981 epithelium Anatomy 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 235000019260 propionic acid Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14776593A | 1993-11-05 | 1993-11-05 | |
| PCT/US1994/012752 WO1995012410A1 (fr) | 1993-11-05 | 1994-11-04 | Conception et production de vaccins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961808D0 NO961808D0 (no) | 1996-05-03 |
| NO961808L true NO961808L (no) | 1996-06-27 |
Family
ID=22522813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961808A NO961808L (no) | 1993-11-05 | 1996-05-03 | Konstruksjon og produksjon av vaksine |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5679349A (fr) |
| EP (1) | EP0726774A4 (fr) |
| JP (1) | JPH09505039A (fr) |
| KR (1) | KR960705582A (fr) |
| CN (2) | CN1087953C (fr) |
| AU (1) | AU1050595A (fr) |
| BR (1) | BR9407988A (fr) |
| CA (1) | CA2175708A1 (fr) |
| CZ (1) | CZ128896A3 (fr) |
| FI (1) | FI961869A (fr) |
| HU (1) | HUT75556A (fr) |
| NO (1) | NO961808L (fr) |
| NZ (1) | NZ276290A (fr) |
| PL (1) | PL314303A1 (fr) |
| RO (1) | RO116045B1 (fr) |
| RU (1) | RU2143920C1 (fr) |
| SG (1) | SG49830A1 (fr) |
| TW (1) | TW448185B (fr) |
| UA (1) | UA42741C2 (fr) |
| WO (1) | WO1995012410A1 (fr) |
| ZA (1) | ZA948590B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002518458A (ja) * | 1998-06-23 | 2002-06-25 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | アジュバント療法 |
| JP2003171291A (ja) * | 1999-10-29 | 2003-06-17 | Takeda Schering-Plough Animal Health Kk | 乳房炎用粘膜予防剤 |
| US6984381B2 (en) | 2002-07-05 | 2006-01-10 | The United States Of America As Represented By The Secretary Of Agriculture | Vaccine for the prevention of bacterial infection of the bovine mammary gland |
| GB0219524D0 (en) | 2002-08-21 | 2002-10-02 | Queen Mary & Westfield College | Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| GB0802931D0 (en) | 2008-02-18 | 2008-03-26 | Queen Mary & Westfield College | Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions |
| CN102716475A (zh) * | 2012-06-29 | 2012-10-10 | 黑龙江省科学院微生物研究所 | 一种奶牛乳房炎疫苗的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0672123A1 (fr) * | 1992-01-08 | 1995-09-20 | The Rockefeller University | Proteine de surface multifonctionnelle de streptococci |
-
1994
- 1994-11-01 ZA ZA948590A patent/ZA948590B/xx unknown
- 1994-11-01 TW TW083110048A patent/TW448185B/zh not_active IP Right Cessation
- 1994-11-04 EP EP95901154A patent/EP0726774A4/fr not_active Withdrawn
- 1994-11-04 CN CN94194775A patent/CN1087953C/zh not_active Expired - Fee Related
- 1994-11-04 WO PCT/US1994/012752 patent/WO1995012410A1/fr not_active Application Discontinuation
- 1994-11-04 CA CA002175708A patent/CA2175708A1/fr not_active Abandoned
- 1994-11-04 AU AU10505/95A patent/AU1050595A/en not_active Abandoned
- 1994-11-04 RO RO96-00919A patent/RO116045B1/ro unknown
- 1994-11-04 HU HU9601191A patent/HUT75556A/hu unknown
- 1994-11-04 KR KR1019960702306A patent/KR960705582A/ko active IP Right Grant
- 1994-11-04 BR BR9407988A patent/BR9407988A/pt active IP Right Grant
- 1994-11-04 SG SG1996007162A patent/SG49830A1/en unknown
- 1994-11-04 RU RU96112189A patent/RU2143920C1/ru active
- 1994-11-04 PL PL94314303A patent/PL314303A1/xx unknown
- 1994-11-04 JP JP7513446A patent/JPH09505039A/ja not_active Withdrawn
- 1994-11-04 UA UA96051776A patent/UA42741C2/uk unknown
- 1994-11-04 CZ CZ961288A patent/CZ128896A3/cs unknown
-
1996
- 1996-05-02 FI FI961869A patent/FI961869A/fi unknown
- 1996-05-03 NO NO961808A patent/NO961808L/no not_active Application Discontinuation
- 1996-07-03 US US08/678,444 patent/US5679349A/en not_active Expired - Fee Related
- 1996-07-04 NZ NZ276290A patent/NZ276290A/en unknown
-
2002
- 2002-03-11 CN CN02107123A patent/CN1380422A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0726774A4 (fr) | 2001-06-27 |
| BR9407988A (pt) | 1996-12-03 |
| PL314303A1 (en) | 1996-09-02 |
| CN1380422A (zh) | 2002-11-20 |
| FI961869A0 (fi) | 1996-05-02 |
| KR960705582A (ko) | 1996-11-08 |
| CN1141000A (zh) | 1997-01-22 |
| NZ276290A (en) | 1997-11-24 |
| ZA948590B (en) | 1996-05-02 |
| CA2175708A1 (fr) | 1995-05-11 |
| TW448185B (en) | 2001-08-01 |
| UA42741C2 (uk) | 2001-11-15 |
| RU2143920C1 (ru) | 2000-01-10 |
| HU9601191D0 (en) | 1996-06-28 |
| NO961808D0 (no) | 1996-05-03 |
| AU1050595A (en) | 1995-05-23 |
| FI961869A (fi) | 1996-05-02 |
| SG49830A1 (en) | 1998-06-15 |
| WO1995012410A1 (fr) | 1995-05-11 |
| EP0726774A1 (fr) | 1996-08-21 |
| CN1087953C (zh) | 2002-07-24 |
| JPH09505039A (ja) | 1997-05-20 |
| RO116045B1 (ro) | 2000-10-30 |
| CZ128896A3 (en) | 1996-10-16 |
| US5679349A (en) | 1997-10-21 |
| HUT75556A (en) | 1997-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2052375C (fr) | Derives de l'hormone parathyroidienne | |
| AU2003210722B2 (en) | Bioactive keratin peptides | |
| DE59007517D1 (de) | Neue proteine mit tnf-hemmender wirkung und ihre herstellung. | |
| US5210075A (en) | Interleukin 6 antagonist peptides | |
| CA1267997A (fr) | Polypeptides, et leur production | |
| Kobayashi et al. | Hymenamides A and B, new proline-rich cyclic heptapeptides from the Okinawan marine sponge Hymeniacidon sp. | |
| US6399053B1 (en) | Methods of enhancing bioactivity of chemokines | |
| MX9604100A (es) | Compuestos ciclicos, inhibidores de la adhesion. | |
| CA1247605A (fr) | Analogues de crf | |
| KR940703854A (ko) | 사람 쿠니즈형 프로테아제 저해제 변이체(a human kunitz-type protease inhibitor variant) | |
| KR870002163A (ko) | 펩티드의 제조방법 | |
| KR850008681A (ko) | 합성펩티드의 제조방법 | |
| EP0601154B1 (fr) | Peptides bpc, leur preparation et utilisation | |
| AR006517A1 (es) | Polipeptido que alcanza un total de alrededor de 30 aminoacidos; sustancia, peptidomimetico y composicion farmaceutica resultantes; usos del polipeptidoy proceso para la sintesis del polipeptido. | |
| DK1000149T3 (da) | 5'-EST'ere til udskilte proteiner identificeret fra hjernevæv | |
| NO961808L (no) | Konstruksjon og produksjon av vaksine | |
| NZ275772A (en) | Haemophilus transferrin receptor genes and proteins including production and use | |
| HUP0000320A2 (hu) | Biológiailag aktív peptidek,és eljárás előállításukra | |
| JPS58116443A (ja) | 新規ペプチドおよびその製法 | |
| US5633345A (en) | Cyclic peptides | |
| TW224975B (fr) | ||
| CA2385659A1 (fr) | Peptides antiarhythmiques | |
| JPH03503178A (ja) | 改変形質転換成長因子αオリゴペプタイド及びその医薬組成物 | |
| TW200517123A (en) | Nogo-A binding molecules and pharmaceutical use thereof | |
| JP2003510257A5 (fr) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |